Lipella Pharmaceuticals Inc. (LIPO) Return on equity 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-261.3%FY2024 · since FY2021: -131.0% → -261.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -261.3% | -114.4 pp |
| FY2023 | -146.9% | -91.3 pp |
| FY2022 | -55.6% | +75.5 pp |
| FY2021 | -131.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice